These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17668416)

  • 1. Pharmacokinetics of 6-hydroxybuspirone and its enantiomers administered individually or following buspirone administration in humans.
    Dockens RC; Tran AQ; Zeng J; Croop R
    Biopharm Drug Dispos; 2007 Oct; 28(7):393-402. PubMed ID: 17668416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range.
    Dockens RC; Salazar DE; Fulmor IE; Wehling M; Arnold ME; Croop R
    J Clin Pharmacol; 2006 Nov; 46(11):1308-12. PubMed ID: 17050795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
    Jagannathan V; Venitz J
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats.
    Wong H; Dockens RC; Pajor L; Yeola S; Grace JE; Stark AD; Taub RA; Yocca FD; Zaczek RC; Li YW
    Drug Metab Dispos; 2007 Aug; 35(8):1387-92. PubMed ID: 17494642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone.
    Kivistö KT; Lamberg TS; Neuvonen PJ
    Pharmacol Toxicol; 1999 Feb; 84(2):94-7. PubMed ID: 10068153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of buspirone following oral administration to rhesus monkeys.
    Marathe PH; Shen F; Markham P; Greene DS
    J Pharm Pharmacol; 1999 May; 51(5):601-7. PubMed ID: 10411220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone.
    Laine K; Ahokoski O; Huupponen R; Hänninen J; Palovaara S; Ruuskanen J; Björklund H; Anttila M; Rouru J
    Eur J Clin Pharmacol; 2003 Dec; 59(10):761-6. PubMed ID: 14566442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influences of aconitine, an active/toxic alkaloid from aconitum, on the oral pharmacokinetics of CYP3A probe drug buspirone in rats.
    Zhu L; Lu L; Guo E; Wu J; Wang Y; Hu M; Liu Z
    Drug Metab Lett; 2014; 8(2):135-44. PubMed ID: 25434398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of oral buspirone in patients with impaired renal function.
    Caccia S; Vigano GL; Mingardi G; Garattini S; Gammans RE; Placchi M; Mayol RF; Pfeffer M
    Clin Pharmacokinet; 1988 Mar; 14(3):171-7. PubMed ID: 3370902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.
    Zuideveld KP; Rusiç-Pavletiç J; Maas HJ; Peletier LA; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1130-7. PubMed ID: 12438536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug.
    Mahmood I; Sahajwalla C
    Clin Pharmacokinet; 1999 Apr; 36(4):277-87. PubMed ID: 10320950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The exposure of highly toxic aconitine does not significantly impact the activity and expression of cytochrome P450 3A in rats determined by a novel ultra performance liquid chromatography-tandem mass spectrometric method of a specific probe buspirone.
    Zhu L; Yang X; Zhou J; Tang L; Xia B; Hu M; Zhou F; Liu Z
    Food Chem Toxicol; 2013 Jan; 51():396-403. PubMed ID: 23085095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspirone.
    Lamberg TS; Kivistö KT; Laitila J; Mårtensson K; Neuvonen PJ
    Eur J Clin Pharmacol; 1998; 54(9-10):761-6. PubMed ID: 9923581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses.
    Barbhaiya RH; Shukla UA; Pfeffer M; Pittman KA; Shrotriya R; Laroudie C; Gammans RE
    Eur J Clin Pharmacol; 1994; 46(1):41-7. PubMed ID: 7911763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected differences in the pharmacokinetics of N-acetyl-DL-leucine enantiomers after oral dosing and their clinical relevance.
    Churchill GC; Strupp M; Galione A; Platt FM
    PLoS One; 2020; 15(2):e0229585. PubMed ID: 32108176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole.
    Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Sep; 62(3):348-54. PubMed ID: 9333111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and the single enantiomers.
    Weber-Grandke H; Hahn G; Mutschler E; Möhrke W; Langguth P; Spahn-Langguth H
    Br J Clin Pharmacol; 1993 Oct; 36(4):363-5. PubMed ID: 12959316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantitation of buspirone and its major metabolite 1-(2-pyrimidinyl)piperazine in human plasma by high-performance liquid chromatography with coulometric detection.
    Odontiadis J; Franklin M
    J Pharm Biomed Anal; 1996 Jan; 14(3):347-51. PubMed ID: 8851759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of reboxetine enantiomers in the dog.
    Frigerio E; Benecchi A; Brianceschi G; Pellizzoni C; Poggesi I; Strolin Benedetti M; Dostert P
    Chirality; 1997; 9(3):303-6. PubMed ID: 9176997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.